
Renault has started a public trial of its on-demand car service on the Paris-Saclay urban campus, according to a press release on Monday, October 14. A panel of around 100 people will use the service — provided by two electric, autonomous, and shared Renault ZOE Cab prototypes — on the campus from October 14 through November 8.
Two cars with different features will be tested, with passengers able to hail them using the mobile app—Marcel Saclay—which was designed specifically for the ZOE Cab experiment. Users can request a car on demand, or book it in advance. The cars will stop en route to pick up another passenger.
Renault stated the pilot would allow it to “test the technical aspects” of the service, which will run Monday through Friday from 11 a.m. to 6 p.m. The experiment, and the feedback from the test riders, will give Renault the chance to identify any necessary adaptations to the service, mobile app and cars.
The ZOE Cab comes equipped with seats that give each passenger a private bubble, and has a variety of “soundscapes” based on “auditive neurostimulation.”
“Soundscapes are processed by the brain as if they were in three dimensions, reproducing an accurate rendition of the sounds, making them seem as close to real as possible for a totally immersive experience,” the release stated.
The cabs also have touchscreens offering ETA and real-time trip data, along with temperature settings, music, and other information.
Waymo announced in June that it was partnering with Renault and Nissan to explore all aspects of driverless mobility services for passengers and deliveries in France and Japan. The collaboration enables Waymo to initially research commercial, legal, and regulatory issues related to Transportation-as-a-Service, with the aim of creating long-term driverless solutions with the world’s largest automaker.
The service will initially launch in France and Japan—home to Renault and Nissan headquarters—with plans to expand to other markets in the future, excluding China.
Full Content: PYMNTS
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas